stockportfolio.pro
Moderna, Inc. EPS (Earnings per Share) 2016–2025
Moderna, Inc. (MRNA) annual earnings per share by fiscal year, computed from SEC filings.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $-7.26 | +21.8% |
| FY 2024 | $-9.28 | +24.7% |
| FY 2023 | $-12.33 | -161.3% |
| FY 2022 | $20.12 | -28.9% |
| FY 2021 | $28.29 | +1543.4% |
| FY 2020 | $-1.96 | -26.5% |
| FY 2019 | $-1.55 | — |
| FY 2018 | $0.00 | — |
| FY 2017 | $0.00 | — |
| FY 2016 | $0.00 | — |
Source: Moderna, Inc. SEC filings — income statement (10-K), split-adjusted. Refreshed nightly.
See the full picture for Moderna, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeModerna, Inc. — frequently asked questions
What is Moderna, Inc.'s earnings per share?
Moderna, Inc. (MRNA) reported earnings per share of $-7.26 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Moderna, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.